drugset / Trial / NCT03498261

A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty

NCT03498261

Phase 1 Active not recruiting 50 enrolled Ohio State University
RandomizedSingle-groupDouble-blindPrevention

Summary

Adding a single preoperative dose of gabapentin to the standard pain regimen will reduce postoperative opioid consumption within the first 72 hours in patients undergoing rhinoplasty.

Timeline

Start
2018-01-30
Primary completion
2025-12-30
Completion
2025-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 900 mg Oral